Adage Capital Partners Portfolio holdings
AUM
$59.3B
1-Year Return
26.26%
This Quarter Return
-1.44%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$40.3B
AUM Growth
-$3.3B
(-7.6%)
Cap. Flow
-$1.67B
Cap. Flow
% of AUM
-4.14%
Top 10 Holdings %
Top 10 Hldgs %
21.18%
Holding
1,160
New
85
Increased
251
Reduced
431
Closed
113
Top Buys
| 1 |
AVLR
Avalara, Inc.
AVLR
|
+$153M |
| 2 |
EOG Resources
EOG
|
+$127M |
| 3 |
TJX Companies
TJX
|
+$121M |
| 4 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
+$113M |
| 5 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$99.1M |
Top Sells
| 1 |
Royalty Pharma
RPRX
|
+$343M |
| 2 |
Textron
TXT
|
+$175M |
| 3 |
Burlington
BURL
|
+$166M |
| 4 |
Exxon Mobil
XOM
|
+$118M |
| 5 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$111M |
Sector Composition
| 1 | Technology | 23.31% |
| 2 | Healthcare | 17.41% |
| 3 | Financials | 15.7% |
| 4 | Consumer Discretionary | 9.78% |
| 5 | Industrials | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
851
Regal Rexnord
RRX
$9.61B
| $2.11M | 0.01% |
15,000
-179,812
| -92% | -$25.2M |
|
852
Larimar Therapeutics
LRMR
$363M
| $2.09M | 0.01% |
651,680
+475,000
| +269% | +$1.52M |
|
|
VAXX
853
DELISTED
Vaxxinity, Inc. Class A Common Stock
VAXX
| $1.98M | ﹤0.01% |
1,001,670
| – | – |
|
|
KDNY
854
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $1.97M | ﹤0.01% |
100,000
-50,000
| -33% | -$983K |
|
855
ESSA Pharma
EPIX
$9.7M
| $1.9M | ﹤0.01% |
1,042,531
| – | – |
|
|
GNFT
856
Genfit
GNFT
$209M
| $1.88M | ﹤0.01% |
+516,055
| New | +$1.88M |
|
857
News Corp Class B
NWS
$18B
| $1.88M | ﹤0.01% |
121,734
-3,600
| -3% | -$55.5K |
|
858
Alkermes
ALKS
$4.48B
| $1.79M | ﹤0.01% |
80,000
-1,010,000
| -93% | -$22.5M |
|
859
Medical Properties Trust
MPW
$2.75B
| $1.78M | ﹤0.01% |
+150,000
| New | +$1.78M |
|
|
CBAY
860
DELISTED
Cymabay Therapeutics
CBAY
| $1.75M | ﹤0.01% |
500,000
| – | – |
|
861
Rezolute
RZLT
$703M
| $1.73M | ﹤0.01% |
631,690
| – | – |
|
862
Kezar Life Sciences
KZR
$29.1M
| $1.72M | ﹤0.01% |
20,000
-28,000
| -58% | -$2.41M |
|
863
TScan Therapeutics
TCRX
$105M
| $1.68M | ﹤0.01% |
550,000
| – | – |
|
864
Cabaletta Bio
CABA
$160M
| $1.65M | ﹤0.01% |
2,541,645
| – | – |
|
|
CNTB
865
Connect Biopharma Holdings Limited Ordinary Shares
CNTB
$96.4M
| $1.65M | ﹤0.01% |
1,277,519
-400,000
| -24% | -$516K |
|
866
Canadian Natural Resources
CNQ
$65.1B
| $1.63M | ﹤0.01% |
+70,000
| New | +$1.63M |
|
867
Aligos Therapeutics
ALGS
$74.3M
| $1.62M | ﹤0.01% |
58,931
| – | – |
|
|
OTLY
868
Oatly Group
OTLY
$520M
| $1.59M | ﹤0.01% |
30,250
-6,750
| -18% | -$355K |
|
869
Vista Energy
VIST
$3.96B
| $1.57M | ﹤0.01% |
166,420
+100,000
| +151% | +$942K |
|
870
NuScale Power
SMR
$4.68B
| $1.51M | ﹤0.01% |
129,260
| – | – |
|
|
ETRN
871
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $1.5M | ﹤0.01% |
200,000
-3,325,000
| -94% | -$24.9M |
|
872
Farmer Brothers
FARM
$44.2M
| $1.41M | ﹤0.01% |
301,229
| – | – |
|
|
UBX
873
DELISTED
Unity Biotechnology
UBX
| $1.38M | ﹤0.01% |
+350,000
| New | +$1.38M |
|
874
Host Hotels & Resorts
HST
$12.2B
| $1.38M | ﹤0.01% |
86,833
+4,900
| +6% | +$77.8K |
|
875
Werner Enterprises
WERN
$1.68B
| $1.37M | ﹤0.01% |
36,545
+25,874
| +242% | +$973K |
|